| NCT07187531 | SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes | NOT_YET_RECRUITING | PHASE2 | 2025-10 | 2028-12 | 2027-11 |
| NCT06435936 | A Study to Assess the Safety of SAB-176 to Prevent the Flu, Given IM in Healthy Adults Compared With Placebo | ACTIVE_NOT_RECRUITING | PHASE1 | 2024-04-22 | 2025-02-01 | 2025-02-01 |
| NCT04850898 | Study of SAB-176 in Healthy Adult Participants | COMPLETED | PHASE2 | 2021-06-23 | 2021-10-08 | 2021-10-08 |
| NCT04469179 | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 | UNKNOWN | PHASE1 | 2020-08-20 | 2021-11 | 2021-02-25 |
| NCT04471038 | Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants | COMPLETED | PHASE1 | 2020-07-29 | 2021-04-19 | 2021-04-19 |
| NCT04468958 | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants | COMPLETED | PHASE1 | 2020-07-01 | 2020-12-23 | 2020-12-23 |